Your browser doesn't support javascript.
loading
Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management.
Veillon, Remi; Sakai, Hiroshi; Le, Xiuning; Felip, Enriqueta; Cortot, Alexis B; Smit, Egbert F; Park, Keunchil; Griesinger, Frank; Britschgi, Christian; Wu, Yi-Long; Melosky, Barbara; Baijal, Shobhit; Jr, Gilberto de Castro; Sedova, Michaela; Berghoff, Karin; Otto, Gordon; Paik, Paul K.
Afiliación
  • Veillon R; CHU Bordeaux, Service des Maladies Respiratoires, Bordeaux, France. Electronic address: remi.veillon@chu-bordeaux.fr.
  • Sakai H; Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan.
  • Le X; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Felip E; Department of Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Cortot AB; Univ. Lille, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020 - UMR-S 1277 - Canther, F-59000 Lille, France.
  • Smit EF; Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Griesinger F; Pius-Hospital, University Medicine Oldenburg, Department of Hematology and Oncology, University Department Internal Medicine-Oncology, Oldenburg, Germany.
  • Britschgi C; Department of Medical Oncology and Hematology, Comprehensive Cancer Center Zurich, University Hospital Zurich, Zurich, Switzerland.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Melosky B; Medical Oncology, The University of British Columbia, Vancouver, Canada.
  • Baijal S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Jr GC; Department of Clinical Oncology, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Sedova M; Cytel Czech Republic, s.r.o., Prague, Czech Republic.
  • Berghoff K; Global Patient Safety, the healthcare business of Merck KGaA, Darmstadt, Germany.
  • Otto G; Global Clinical Development, the healthcare business of Merck KGaA, Darmstadt, Germany.
  • Paik PK; Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY.
Clin Lung Cancer ; 23(4): 320-332, 2022 06.
Article en En | MEDLINE | ID: mdl-35466070
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Neoplasias Pulmonares Límite: Aged / Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Neoplasias Pulmonares Límite: Aged / Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article